Oncotelic Therapeutics annual free cash flow
2009
2014
2015
Oncotelic Therapeutics Free Cash Flow (FCF) History (OTLC)
Oncotelic Therapeutics reported −$11.9M in free cash flow for fiscal 2015, an increase of $228,000 from the previous fiscal year.
View full Oncotelic Therapeutics company overviewOncotelic Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2015 | 2015-12-31 | −$11.9M | $228,000 | — | — |
| 2014 | 2014-12-31 | −$12.2M | $16.6M | — | — |
| 2009 | 2009-12-31 | −$28.8M | — | — | — |
Oncotelic Therapeutics quarterly free cash flow
Q3.15
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2015 | 2015-09-30 | −$2.8M | — | — | — |
Oncotelic Therapeutics free cash flow growth trends
Oncotelic Therapeutics's latest reported quarter, Q3 2015, generated −$2.8M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Oncotelic Therapeutics filings at SEC.gov ↗